The company’s stock JNJ is climbing in morning trading, boosted by better-than-expected second-quarter results and raised ...

Johnson & Johnson (NYSE:JNJ) ranks among the stocks to benefit from an onshoring boom. On July 23, Erste Group raised the ...

Johnson & Johnson is a globally diversified healthcare conglomerate with two main operating segments. The Innovative Medicine ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Johnson & Johnson (NYSE:JNJ) is one of the top cheap pharmaceutical stocks to buy now. On July 29, Johnson & Johnson ...

Johnson & Johnson (NYSE:JNJ) has a sizable and broadly positioned operation, with strong representation in both the medical ...

Johnson & Johnson (NYSE: JNJ) Q2 2025 Earnings Conference Call July 16, 2025 8:30 AM ET Company Participants Darren Snellgrove - Corporate Participant Jennifer L. Taubert - Executive VP ...

Johnson & Johnson (NYSE: JNJ) reports earnings this morning. Yesterday, stocks across the healthcare sector sold off, with the XLV ETF that tracks healthcare stocks falling 1.8%.

Johnson & Johnson reported revenues of $21.89 billion in the last reported quarter, representing a year-over-year change of +2.4%. EPS of $2.77 for the same period compares with $2.71 a year ago.

Johnson & Johnson (NYSE:JNJ) is included among the 10 Best Dividend Stocks to Buy for Retirement. Johnson & Johnson (NYSE:JNJ ...